Old Web
English
Sign In
Acemap
>
authorDetail
>
M. Sterba
M. Sterba
Medicine
Immunology
Diabetes mellitus
Syk kinase
Bioavailability
4
Papers
1
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Excellent response of VX2 liver metastases to iri delivered from 2 types of microspheres
2014
Journal of Vascular and Interventional Radiology
J. Namur
Florentina Pascale
M. Sterba
Noboru Maeda
S. Ghegediban
V. Verret
Michel Wassef
Alexandre Laurent
Show All
Source
Cite
Save
Citations (0)
ABSTRACTS OF ORAL PRESENTATIONS
2014
M. Sterba
Hind Mehel
Julius Emons
Christiane Vettel
Danilo Seppelt
Lars S. Maier
Audrey Varin
Viacheslav O. Nikolaev
Rodolphe Fischmeister
Show All
Source
Cite
Save
Citations (0)
An orally bioavailable inhibitor of Syk kinase (R406) inhibits, dose responsively, human basophil CD63 expression following ex vivo feepsilon receptor stimulation
2005
Arthritis & Rheumatism
Elliott B. Grossbard
Timothy Mant
Stipo Jurcevic
M. Sterba
Show All
Source
Cite
Save
Citations (0)
A multiple dose study of an orally bioavailable inhibitor of SyK-kinase (r406) in human volunteers: Safety, pharmacokinetics (PK) and pharmacodynamics (PD)
2005
Arthritis & Rheumatism
Elliott B. Grossbard
Timothy Mant
Stipo Jurcevic
M. Sterba
Show All
Source
Cite
Save
Citations (1)
1